NCT00099749View on ClinicalTrials.gov

Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

255

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

April 30, 2006

Conditions
Kidney Transplantation
Interventions
DRUG

FTY 720

Trial Locations (5)

19104

University of Pennsylvania, Philadelphia

60153

Loyola University Medical Center, Maywood

62781

SIU School of Medicine, Springfield

07039

St. Barnabas Medical Center, Livingston

02903

Rhode Island Hospital, Providence

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY